ASBPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ASBPW
Aspire-Lakewood Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.41−0.37 (-4.21%)
Close on Oct 19, 2026
- Market cap
- $8.73M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$400.11 (−97.94%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Aspire-Lakewood Holdings, Inc. reported revenue of $97.66K for the twelve months to Jun 30, 2026.
Revenue
$97.66K
TTM Q2 2026
Operating income
-$7.32M
TTM Q2 2026
EPS, diluted
-$16.38
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $8.73M
- P/E ratio
- –
- Price to sales
- 89.38
- Price to book
- 0.74
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $97.66K
- Net income
- -$11.05M
- EPS, diluted
- -$16.38
- Book value per share
- $11.33
- Diluted shares
- 1M
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Revenue
$97.66K
Gross profit
-$24.45K
Operating income
-$7.32M
Net income
-$11.05M
EPS, diluted
–
Reported periodTrailing twelve months